N-acetylcysteine protects human periodontal ligament fibroblasts from pyroptosis and osteogenic differentiation dysfunction through the SIRT1/NF-κB/Caspase-1 signaling pathway

Objective: This study was aimed to determine whether N-acetylcysteine (NAC) could inhibit lipopolysaccharides / adenosine triphosphate (ATP)-induced pyroptosis and alleviate the damage of osteogenic differentiation in human periodontal ligament fibroblasts (hPDLFs). Furthermore, this study detected whether NAC acted effec-tively by modulating the silent information regulator 2 homolog 1 (SIRT1)/ the nuclear factor-Kappa B (NF-Kappa B)/ Caspase-1 signaling pathway in hPDLFs.Design: Cell Counting Kit-8 assay was employed to determine the appropriate concentration of NAC for the follow-up experiments. To explore the effect and the underlying mechanisms of NAC on pyroptosis and osteo-genic differentiation in hPDLFs, intracellular reactive oxygen species levels were detected using 2 ',7 '-Dichlor-odihydrofluorescein Diacetate kits. Moreover, SIRT1 inhibitor, SIRT1 activator, NF-Kappa B inhibitor and Caspase-1 inhibitor were applied, the incidence of pyroptosis was detected by flow cytometry, the osteogenic differentia-tion of hPDLFs was observed using alkaline phosphatase and alizarin red staining, Real-time quantitative po-lymerase chain reaction and Western Blot were used to detect the expression of relevant factors, the release of interleukin-1 beta, interleukin-18 and lactate dehydrogenase were detected by Enzyme-linked immunosorbent assay.Results: The results demonstrated that NAC protected hPDLFs from lipopolysaccharides/ATP-induced damage, alleviating pyroptosis and osteogenic differentiation dysfunction. Moreover, NAC abrogated the inhibition of SIRT1 activity by scavenging reactive oxygen species, thereby reduced pyroptosis and osteogenic differentiation dysfunction by inhibiting the NF-Kappa B/Caspase-1signaling pathway.Conclusion: NAC could inhibit pyroptosis and osteogenic differentiation dysfunction of hPDLFs by scavenging reactive oxygen species to regulate the SIRT1/NF-Kappa B/Caspase-1 signaling axis.